Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that Synteract Inc. has attained the study build accreditation in Medidata’s channel partner program. With this accreditation, Synteract can now provide the full suite of Medidata Rave® electronic data capture (EDC) and clinical data management (CDM) services to sponsors.

A channel partner since June 2010, Synteract is a full-service contract research organization (CRO) with an increasing global presence and extensive experience working with emerging biotech, pharmaceutical and medical device sponsors. Impressed by Medidata Rave’s flexibility and scalability, Synteract viewed this partnership milestone as important to its continued efforts to expand internationally while providing sponsors with the highest level of Rave support.

"Attaining the Medidata Rave study build accreditation demonstrates our dedication to bringing optimal efficiencies to our customers for global trials of all sizes," said Stewart Bieler, chief operating officer, Synteract. "The implementation success we’ve experienced due to Rave’s flexibility and monitoring offerings made it clear that expanding our partnership with Medidata would help us move toward our next stage of growth."

The new accreditation enables Synteract to serve as a single source for sponsors to acquire all Rave-related services, including end user training, study build, reporting, outputs, integrations and migrations. With more than 16 years of experience providing responsive, flexible service, Synteract can manage all aspects of trials, including EDC activities.

"Since becoming a Medidata partner last year, Synteract has quickly realized the benefits of the program, expanding its reach to include the wide range of sponsors who are relying more frequently on Medidata Rave for global trials," said Graham Bunn, vice president of partnerships and alliances, Medidata Solutions. "As the CRO market continues to evolve, Synteract recognizes partnership with Medidata as necessary to its ability to maintain steady growth and competitiveness."

Medidata first announced its channel partner program in April 2005 to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, the program has grown to include more than 30 partners, ranging from smaller clinical consultancies to large, global CROs.